Form 8-K - Current report:
SEC Accession No. 0001104659-25-015647
Filing Date
2025-02-20
Accepted
2025-02-20 16:01:17
Documents
14
Period of Report
2025-02-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257203d1_8k.htm   iXBRL 8-K 28836
2 EXHIBIT 99.1 tm257203d1_ex99-1.htm EX-99.1 14701
  Complete submission text file 0001104659-25-015647.txt   221274

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hook-20250220.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20250220_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20250220_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT tm257203d1_8k_htm.xml XML 3830
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 25645160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)